Literature DB >> 12948865

Contribution of the Ah receptor to the phenolic antioxidant-mediated expression of human and rat UDP-glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5L cells.

Peter A Münzel1, Stephan Schmohl, Felicitas Buckler, Jan Jaehrling, Frank T Raschko, Christoph Köhle, Karl Walter Bock.   

Abstract

UDP-glucuronosyltransferases (UGTs) represent major phase II enzymes of drug metabolism which are regulated in a tissue-specific manner by endogenous and environmental factors. Among the latter, aryl hydrocarbon receptor (AhR) agonists such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and phenolic antioxidants such as tert-butylhydroquinone (tBHQ) are known to induce the expression of human UGT1A6 in Caco-2 cells. While binding of the TCDD-activated AhR to one xenobiotic response element (XRE) in the 5'-flanking regulatory region of UGT1A6 was characterised previously, the mechanism responsible for tBHQ induction is unknown. Therefore, it was investigated whether antioxidant response elements (AREs) are involved in tBHQ induction of UGT1A6. Transfectants of 3 kb of its regulatory region and its deletion mutants were treated with tBHQ. These studies suggested a region with approximately 2-fold induction, including an ARE-like motif, 15 bp downstream of the previously characterised XRE. Transfectants of the point-mutated ARE-like motif showed marginally reduced response to tBHQ, but surprisingly, loss of response to TCDD, suggesting interference of flanking proteins with the AhR/Arnt complex. Coordinate responses of UGT activity after treatment with TCDD or tBHQ were also observed in rat hepatoma 5L cells, mutants without the AhR and with recomplemented AhR. The results suggest a contribution of the AhR pathway and of proteins binding to the XRE flanking region to the induction of human UGT1A6 by both AhR agonists and phenolic antioxidants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948865     DOI: 10.1016/s0006-2952(03)00389-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

Review 1.  Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR.

Authors:  Antonia H Tolson; Hongbing Wang
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

Review 2.  Activation of xenobiotic receptors: driving into the nucleus.

Authors:  Haishan Li; Hongbing Wang
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-04       Impact factor: 4.481

Review 3.  Aryl hydrocarbon receptor control of adaptive immunity.

Authors:  Francisco J Quintana; David H Sherr
Journal:  Pharmacol Rev       Date:  2013-08-01       Impact factor: 25.468

4.  Transcriptional factor aryl hydrocarbon receptor (Ahr) controls cardiovascular and respiratory functions by regulating the expression of the Vav3 proto-oncogene.

Authors:  Vincent Sauzeau; José M Carvajal-González; Adelaida S Riolobos; María A Sevilla; Mauricio Menacho-Márquez; Angel C Román; Antonio Abad; María J Montero; Pedro Fernández-Salguero; Xosé R Bustelo
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

Review 5.  Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters.

Authors:  Yakun Chen; Yong Tang; Changxiong Guo; Jiuhui Wang; Debasish Boral; Daotai Nie
Journal:  Biochem Pharmacol       Date:  2012-02-04       Impact factor: 5.858

6.  Interaction between oxidative stress sensor Nrf2 and xenobiotic-activated aryl hydrocarbon receptor in the regulation of the human phase II detoxifying UDP-glucuronosyltransferase 1A10.

Authors:  Sandra Kalthoff; Ursula Ehmer; Nicole Freiberg; Michael P Manns; Christian P Strassburg
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

Review 7.  Nrf2 Weaves an Elaborate Network of Neuroprotection Against Stroke.

Authors:  Shuai Jiang; Chao Deng; Jianjun Lv; Chongxi Fan; Wei Hu; Shouyin Di; Xiaolong Yan; Zhiqiang Ma; Zhenxing Liang; Yang Yang
Journal:  Mol Neurobiol       Date:  2016-02-05       Impact factor: 5.590

8.  Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters.

Authors:  Guoxiang Shen; Ah-Ng Kong
Journal:  Biopharm Drug Dispos       Date:  2009-10       Impact factor: 1.627

9.  Effects of tert-butylhydroquinone on intestinal inflammatory response and apoptosis following traumatic brain injury in mice.

Authors:  Wei Jin; Hongbin Ni; Yuxiang Dai; Handong Wang; Tianyu Lu; Jun Wu; Jian Jiang; Weibang Liang
Journal:  Mediators Inflamm       Date:  2011-01-11       Impact factor: 4.711

10.  Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha.

Authors:  Brian N Chorley; Michelle R Campbell; Xuting Wang; Mehmet Karaca; Deepa Sambandan; Fatu Bangura; Peng Xue; Jingbo Pi; Steven R Kleeberger; Douglas A Bell
Journal:  Nucleic Acids Res       Date:  2012-05-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.